Mucosa-associated Lymphoid Tissue (MALT) Lymphoma
What is Mucosa-associated Lymphoid Tissue (MALT) Lymphoma?
Mucosa-associated lymphoid tissue lymphoma, or MALT lymphoma, is a slow-growing cancer of the immune system. It starts in special immune cells called B lymphocytes that normally protect the mucous membranes lining your digestive tract, lungs, eyes, and other organs. These cells become cancerous and begin to grow out of control, forming tumors in the affected tissue.
MALT lymphoma most often develops in the stomach, where it is strongly linked to infection with Helicobacter pylori bacteria. This common bacteria causes chronic inflammation in the stomach lining, which over many years can trigger abnormal cell growth. The condition can also affect the small intestine, salivary glands, thyroid, lungs, eyes, and skin. It typically grows very slowly and may stay localized for long periods before spreading.
This type of lymphoma is considered one of the more treatable forms of cancer. Many people with stomach MALT lymphoma can be cured by treating the underlying H. pylori infection with antibiotics. When caught early and managed properly, the outlook is generally positive. Understanding your risk factors and getting appropriate testing can help detect this condition when treatment is most effective.
Symptoms
- Stomach pain or discomfort in the upper abdomen
- Unexplained weight loss without trying to lose weight
- Loss of appetite or feeling full after eating small amounts
- Nausea or vomiting that persists
- Indigestion or heartburn that does not go away
- Swelling or lumps in affected areas like the neck or under the jaw
- Night sweats that soak through your clothes or bedding
- Fatigue that interferes with daily activities
- Low-grade fever that comes and goes
- Blood in stool or black, tarry stools
Many people with MALT lymphoma have no symptoms at all in the early stages. The condition often develops slowly over months or years. Some people only discover they have MALT lymphoma when undergoing testing for other digestive problems or during routine examinations. If you have persistent H. pylori infection or ongoing stomach symptoms, talk to your doctor about appropriate testing.
Concerned about Mucosa-associated Lymphoid Tissue (MALT) Lymphoma? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
The primary cause of stomach MALT lymphoma is long-term infection with Helicobacter pylori bacteria. This bacteria causes ongoing inflammation in the stomach lining, which can trigger immune cells to become cancerous over time. Not everyone with H. pylori develops MALT lymphoma, but the infection is found in about 90% of people with stomach MALT lymphoma. Other chronic infections and autoimmune conditions can also trigger MALT lymphoma in different parts of the body. For example, Chlamydia psittaci can cause eye MALT lymphoma, while autoimmune disorders like Sjögren syndrome increase risk in the salivary glands.
Risk factors include age over 60, though it can occur at any age. Having a weakened immune system from conditions like HIV or taking immunosuppressive medications also increases risk. People with autoimmune diseases that cause chronic inflammation are more likely to develop MALT lymphoma in the affected organs. Geographic location matters too, as H. pylori infection rates are higher in certain regions. Previous radiation exposure and a family history of lymphoma may also play a role. Lifestyle factors like smoking may contribute to risk, though the connection is less clear than with H. pylori infection.
How it's diagnosed
Diagnosing MALT lymphoma requires multiple tests and procedures. Your doctor will start with a physical exam and medical history. Blood tests can check for H. pylori infection using the Helicobacter Pylori antigen test. This test helps identify if the bacteria is present, which is important for both diagnosis and treatment planning. Additional blood work may include complete blood counts, liver and kidney function tests, and lactate dehydrogenase levels to assess overall health and disease extent.
The definitive diagnosis requires a tissue biopsy from the affected area. During an upper endoscopy for stomach MALT lymphoma, a doctor inserts a thin tube with a camera down your throat to view the stomach lining and take tissue samples. A pathologist examines these samples under a microscope to confirm the presence of lymphoma cells. Imaging tests like CT scans, MRI, or PET scans help determine if the lymphoma has spread to other parts of the body. Talk to your doctor about specialized testing options for MALT lymphoma diagnosis and staging.
Treatment options
- Antibiotic therapy to eliminate H. pylori infection, often including two antibiotics plus a proton pump inhibitor for 10 to 14 days
- Wait and watch approach for slow-growing, localized disease with regular monitoring through endoscopy and imaging
- Radiation therapy targeting the specific area affected by lymphoma, especially for early-stage disease
- Chemotherapy using medications that kill cancer cells, typically reserved for advanced or widespread disease
- Immunotherapy with rituximab, a targeted antibody that attacks lymphoma cells
- Surgery to remove affected tissue, though this is less common now due to effective medical treatments
- Dietary changes to support gut health, including eating anti-inflammatory foods and avoiding stomach irritants
- Stress management techniques to support immune system function and overall wellbeing
- Regular follow-up care with repeat endoscopies and imaging to monitor treatment response and check for recurrence
- Treatment of underlying autoimmune conditions if present to reduce chronic inflammation
Frequently asked questions
MALT lymphoma is a slow-growing type of non-Hodgkin lymphoma that starts in mucous membrane tissues. Unlike more aggressive lymphomas, it typically grows very slowly and often stays localized for years. It responds well to treatment, especially when caught early, and many cases can be cured by treating the underlying infection. Other lymphomas may grow faster and require more intensive treatment approaches.
Yes, in many cases of early-stage stomach MALT lymphoma, eliminating H. pylori with antibiotics can cure the cancer. Studies show that 60 to 80% of people with localized stomach MALT lymphoma go into complete remission after successful H. pylori treatment. The lymphoma cells often disappear over several months as the chronic inflammation resolves. Regular monitoring is needed to confirm the cancer is gone and does not return.
MALT lymphoma typically develops after many years of chronic H. pylori infection, often decades. The bacteria causes ongoing inflammation that gradually leads to abnormal changes in immune cells. Not everyone with H. pylori infection develops MALT lymphoma, and the exact timeline varies from person to person. Early detection and treatment of H. pylori can help prevent the development of lymphoma.
Early MALT lymphoma often causes no symptoms at all. When symptoms do appear, they may include persistent stomach pain, indigestion, or feeling full quickly after eating. Unexplained weight loss, loss of appetite, and ongoing nausea are other potential signs. Because these symptoms overlap with many common digestive issues, it is important to see a doctor if they persist for more than a few weeks, especially if you have known H. pylori infection.
MALT lymphoma is not typically inherited directly from parents to children. However, certain genetic factors may influence your immune response and susceptibility to infections like H. pylori. Some inherited conditions that affect immune function may slightly increase lymphoma risk overall. The primary cause is environmental exposure to H. pylori or other chronic infections rather than inherited genetic mutations.
Preventing and treating H. pylori infection is the most important step for stomach MALT lymphoma prevention. This includes practicing good hygiene, washing hands regularly, and ensuring food and water safety. Avoiding smoking may reduce overall lymphoma risk. Eating a diet rich in fruits, vegetables, and anti-inflammatory foods supports immune health. Getting prompt treatment for infections and managing autoimmune conditions can also help reduce chronic inflammation that contributes to cancer development.
Monitoring frequency depends on your treatment and response. After successful H. pylori treatment, you will typically have repeat endoscopies every 3 to 6 months initially to confirm the lymphoma is responding. Once in remission, follow-up may be every 6 to 12 months for several years. Your doctor will also order periodic blood tests and imaging as needed. Long-term surveillance is important because MALT lymphoma can recur even years after successful treatment.
Yes, MALT lymphoma can spread, though it usually stays localized for long periods. When it does spread, it typically moves to other mucosa-associated lymphoid tissues first, like other parts of the digestive tract or nearby lymph nodes. In advanced cases, it can spread to the bone marrow or other organs. Early detection and treatment help prevent spread and improve outcomes significantly.
Blood tests help monitor MALT lymphoma and check for H. pylori infection. The Helicobacter Pylori antigen test detects active infection and confirms if treatment successfully eliminated the bacteria. Complete blood counts check for anemia or abnormal cell counts. Lactate dehydrogenase levels may indicate disease activity. Other tests measure liver and kidney function to ensure organs are working properly and to guide treatment decisions.
MALT lymphoma has one of the best success rates among lymphomas, especially when caught early. For localized stomach MALT lymphoma treated with H. pylori antibiotics, 60 to 80% of people achieve complete remission. Five-year survival rates exceed 90% for early-stage disease. Even for advanced cases, treatment with chemotherapy, radiation, or immunotherapy is often effective. The slow-growing nature of MALT lymphoma means many people live for years with proper treatment and monitoring.